Table 2.
Cost scenarios for panitumumab if the cost of expanded RAS testing is the same or 2, 10, or 30 times the cost of standard KRAS testing

Cost scenarios for panitumumab if the cost of expanded RAS testing is the same or 2, 10, or 30 times the cost of standard KRAS testing
